CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Champions Oncology, Inc. - CSBR CFD

3.74
10.31%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.12
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 4.17
Open 4.05
1-Year Change -33.39%
Day's Range 3.38 - 4.41
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 10, 2024 3.74 -0.31 -7.65% 4.05 4.49 3.38
Sep 9, 2024 4.17 0.15 3.73% 4.02 4.22 4.02
Sep 6, 2024 4.24 0.22 5.47% 4.02 4.24 4.02
Sep 5, 2024 4.13 -0.11 -2.59% 4.24 4.24 4.07
Sep 4, 2024 4.13 0.11 2.74% 4.02 4.13 4.02
Sep 3, 2024 4.02 -0.12 -2.90% 4.14 4.31 4.02
Aug 30, 2024 3.87 -0.37 -8.73% 4.24 4.24 3.86
Aug 29, 2024 3.95 -0.30 -7.06% 4.25 4.44 3.81
Aug 28, 2024 4.25 -0.06 -1.39% 4.31 4.50 4.04
Aug 27, 2024 4.45 -0.06 -1.33% 4.51 4.51 4.21
Aug 26, 2024 4.49 -0.09 -1.97% 4.58 4.60 4.40
Aug 23, 2024 4.57 0.37 8.81% 4.20 4.94 4.20
Aug 22, 2024 4.40 0.27 6.54% 4.13 4.40 4.13
Aug 21, 2024 4.30 0.34 8.59% 3.96 4.32 3.80
Aug 20, 2024 4.35 0.06 1.40% 4.29 4.35 4.29
Aug 19, 2024 4.35 -0.04 -0.91% 4.39 4.40 4.07
Aug 16, 2024 4.46 0.07 1.59% 4.39 4.46 4.38
Aug 15, 2024 4.49 0.03 0.67% 4.46 4.49 4.39
Aug 14, 2024 4.54 0.08 1.79% 4.46 4.54 4.46
Aug 13, 2024 4.46 0.00 0.00% 4.46 4.46 4.46

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Champions Oncology, Inc. Company profile

About Champions Oncology Inc

Champions Oncology, Inc. is engaged in creating transformative technology solutions to be utilized in oncology drug discovery and development. This technology includes the Company’s in-vivo, ex-vivo and biomarker platforms, oncology software solutions, and computational-based discovery platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology. The Company’s software as a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. The Company’s drug discovery and development business leverages the computational and experimental capabilities within its platforms. Their discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify novel therapeutic targets.

Financial summary

BRIEF: For the nine months ended 31 January 2022, Champions Oncology Inc revenues increased 19% to $36.2M. Net income decreased 14% to $892K. Revenues reflect Pharmacology services segment increase of 66% to $34.5M, Other segment increase from $101K to $1.7M. Net income was offset by research and development increase of 32% to $6.8M (expense), general and administratiojn increase of 32% to $5.9M (expense).

Equity composition

Common Stock $.001 Par, 01/11, 50M auth., 36,853,000 issd. less 1,236,000 shs. in Treas. @ $292K. Insiders & strategic holders own 64.79%. Public Offering 9/85, 40M Units (1 sh. com. + 3 warrants) @ $.01 by the Company. 02/07, Name changedfrom Champions Sports Inc.08/15, 1-for-12 Reverse stock split.

Industry: Biotechnology & Medical Research (NEC)

Suite 619
855 N. Wolfe Street
BALTIMORE
MARYLAND 21205
US

News

Market analysis: US CPI and PPI

Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.

07:56, 10 September 2024

Introducing Newsquawk: your new in-platform newsfeed

We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.

14:09, 20 August 2024

Jackson Hole Preview: All eyes on Powell and Gold

The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.

15:24, 19 August 2024

All eyes on inflation: US and UK CPI take centre stage

Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.

14:41, 13 August 2024

European stocks face resistance in their attempt to recover

European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.

13:56, 9 August 2024

Global selloff continues on US economy fears

Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.

14:40, 5 August 2024

FOMC PREVIEW

Markets believe the Federal reserve will continue to leave their monetary policy unchanged at the meeting next week.

14:09, 1 August 2024

People also watch

Oil - Crude

66.06 Price
+0.260% 1D Chg, %
Long position overnight fee 0.0278%
Short position overnight fee -0.0497%
Overnight fee time 21:00 (UTC)
Spread 0.030

US100

18,714.60 Price
-0.490% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

0.54 Price
-1.790% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,520.98 Price
+0.190% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 640,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading